ZURICH (Reuters) - With women hardest hit by migraine headaches, Swiss drugmaker Novartis is gearing up its marketing message to counteract sexism that it worries might become a barrier to adoption of its new medicine Aimovig.
from Reuters: Top News https://ift.tt/2LgbziB
via
IFTTT
0 comments:
Post a Comment